Rebound thrombocytosis is associated with response in AML patients treated with venetoclax and hypomethylating agents.

作者: Ibrahim Aldoss , Vinod Pullarkat , Matthew Mei , Anthony Stein , Stephen J. Forman

DOI: 10.1002/AJH.26117

关键词:

摘要:

参考文章(5)
M. E. Daly, Determinants of platelet count in humans. Haematologica. ,vol. 96, pp. 10- 13 ,(2011) , 10.3324/HAEMATOL.2010.035287
Philipp J. Rauch, Jana M. Ellegast, Corinne C. Widmer, Kristin Fritsch, Jeroen S. Goede, Peter J. M. Valk, Bob Löwenberg, Hitoshi Takizawa, Markus G. Manz, MPL expression on AML blasts predicts peripheral blood neutropenia and thrombocytopenia. Blood. ,vol. 128, pp. 2253- 2257 ,(2016) , 10.1182/BLOOD-2016-04-711986
Hartmut Döhner, Elihu Estey, David Grimwade, Sergio Amadori, Frederick R. Appelbaum, Thomas Büchner, Hervé Dombret, Benjamin L. Ebert, Pierre Fenaux, Richard A. Larson, Ross L. Levine, Francesco Lo-Coco, Tomoki Naoe, Dietger Niederwieser, Gert J. Ossenkoppele, Miguel Sanz, Jorge Sierra, Martin S. Tallman, Hwei-Fang Tien, Andrew H. Wei, Bob Löwenberg, Clara D. Bloomfield, Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel Blood. ,vol. 129, pp. 424- 447 ,(2017) , 10.1182/BLOOD-2016-08-733196
Bianca R. Schnell, Katja Seipel, Ulrike Bacher, Barbara Jeker, Beatrice U. Mueller, Yara Banz, Urban Novak, Thomas Pabst, Rebound Thrombocytosis after Induction Chemotherapy is a Strong Biomarker for Favorable Outcome in AML Patients. HemaSphere. ,vol. 3, ,(2019) , 10.1097/HS9.0000000000000180
Courtney D. DiNardo, Brian A. Jonas, Vinod Pullarkat, Michael J. Thirman, Jacqueline S. Garcia, Andrew H. Wei, Marina Konopleva, Hartmut Döhner, Anthony Letai, Pierre Fenaux, Elizabeth Koller, Violaine Havelange, Brian Leber, Jordi Esteve, Jianxiang Wang, Vlatko Pejsa, Roman Hájek, Kimmo Porkka, Árpád Illés, David Lavie, Roberto M. Lemoli, Kazuhito Yamamoto, Sung-Soo Yoon, Jun-Ho Jang, Su-Peng Yeh, Mehmet Turgut, Wan-Jen Hong, Ying Zhou, Jalaja Potluri, Keith W. Pratz, Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia The New England Journal of Medicine. ,vol. 383, pp. 617- 629 ,(2020) , 10.1056/NEJMOA2012971